UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Emerging therapeutic interventions for idiopathic pulmonary fibrosis

Expert opinion on investigational drugs, 2014-07, Vol.23 (7), p.893-910

2014

Volltextzugriff (PDF)

Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics

Expert opinion on investigational drugs, 2010-01, Vol.19 (1), p.27-43

2010

Volltextzugriff (PDF)

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain

Expert opinion on investigational drugs, 2010-04, Vol.19 (4), p.455-468

2010

Volltextzugriff (PDF)

Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice

European journal of pharmacology, 2020-11, Vol.886, p.173391-173391, Article 173391

2020

Volltextzugriff (PDF)

MK2: a novel molecular target for anti-inflammatory therapy

Expert opinion on therapeutic targets, 2008-08, Vol.12 (8), p.921-936

2008

Volltextzugriff (PDF)

Pharmacology of a Novel, Orally Active PDE4 Inhibitor

Pharmacology, 2009-01, Vol.83 (5), p.275-286

2009

Volltextzugriff (PDF)

Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis

Expert opinion on investigational drugs, 2008-05, Vol.17 (5), p.641-659

2008

Volltextzugriff (PDF)

Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: A novel approach for overcoming resistance in anticancer treatment

European journal of pharmacology, 2011-09, Vol.667 (1), p.56-65

2011

Volltextzugriff (PDF)

Design and Synthesis of 3,5-Disubstituted-1,2,4-Oxadiazoles as Potent Inhibitors of Phosphodiesterase4B2

Chemical biology & drug design, 2012-05, Vol.79 (5), p.810-818

2012

Volltextzugriff (PDF)

Therapeutic benefit of PDE4 inhibitors in inflammatory diseases

Current opinion in investigational drugs (London, England : 2000), 2007-05, Vol.8 (5), p.364

2007

Volltextzugriff (PDF)

RBx10080307, a dual EGFR/IGF-1R inhibitor for anticancer therapy

European journal of pharmacology, 2013-07, Vol.711 (1-3), p.19-26

2013

Volltextzugriff (PDF)

Chronic obstructive pulmonary disease: role of matrix metalloproteases and future challenges of drug therapy

Expert opinion on investigational drugs, 2007-07, Vol.16 (7), p.1069-1078

2007

Volltextzugriff (PDF)

Prostaglandin E 2 synthase inhibition as a therapeutic target

Expert opinion on therapeutic targets, 2009-07, Vol.13 (7), p.849-865

2009

Volltextzugriff (PDF)

Prostaglandin E2 synthase inhibition as a therapeutic target

Expert opinion on therapeutic targets, 2009-07, Vol.13 (7), p.849-865

2009

Volltextzugriff (PDF)

Synthesis of 4β-amido and 4β-sulphonamido analogues of podophyllotoxin as potential antitumour agents

Bioorganic & medicinal chemistry, 2003-11, Vol.11 (23), p.5135-5142

2003

Volltextzugriff (PDF)

An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors

Analytical biochemistry, 2008-09, Vol.380 (1), p.143-145

2008

Volltextzugriff (PDF)

Development of a cell death-based method for the screening of nuclear factor-κB inhibitors

Journal of immunological methods, 2008-06, Vol.335 (1), p.126-131

2008

Volltextzugriff (PDF)

Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: A novel, long acting muscarinic receptor antagonist

European journal of pharmacology, 2011-05, Vol.658 (2), p.219-228

2011

Volltextzugriff (PDF)

Development of cell death-based method for the selectivity screening of caspase-1 inhibitors

Cytotechnology (Dordrecht), 2009-07, Vol.60 (1-3), p.77-83

2009

Volltextzugriff (PDF)

Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase

International immunopharmacology, 2010-04, Vol.10 (4), p.467-473

2010

Volltextzugriff (PDF)

Synthesis and biological evaluation of new 4β-anilino- and 4β-imido-substituted podophyllotoxin congeners

Bioorganic & medicinal chemistry, 2005-11, Vol.13 (22), p.6218-6225

2005

Volltextzugriff (PDF)

Therapeutic potential of Aurora kinase inhibitors in cancer

Current opinion in investigational drugs (London, England : 2000), 2006-12, Vol.7 (12), p.1044

2006

Volltextzugriff (PDF)

Design, synthesis, biological evaluation and QSAR studies of novel bisepipodophyllotoxins as cytotoxic agents

Bioorganic & medicinal chemistry, 2004-08, Vol.12 (15), p.4197-4209

2004

Volltextzugriff (PDF)

Progress in the development of small molecule inhibitors of insulin-like growth factor-1 receptor kinase

Expert opinion on therapeutic patents, 2007-01, Vol.17 (1), p.25-35

2007

Volltextzugriff (PDF)

Synthesis and Biological Activity of New 4β-N-Heteroaryl Analogues of Podophyllotoxin

Letters in drug design & discovery, 2006-04, Vol.3 (3), p.205-209

2006

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(26)
Pharmacology & Pharmacy
(22)
Humans
(20)
Animals
(15)
Biological And Medical Sciences
(9)
Inflammation
(9)
Biochemistry & Molecular Biology
(7)
Chemistry
(7)
Chemistry, Medicinal
(7)
Medical Sciences
(7)
Mice
(7)
Pharmacology. Drug Treatments
(7)
Antineoplastic Agents - Pharmacology
(6)
Female
(6)
Physical Sciences
(6)
Male
(5)
Pharmacology
(5)
Rats
(5)
Antineoplastic Agents
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Emerging therapeutic interventions for idiopathic pulmonary fibrosis

Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain

Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice

MK2: a novel molecular target for anti-inflammatory therapy

Pharmacology of a Novel, Orally Active PDE4 Inhibitor

Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis

Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: A novel approach for overcoming resistance in anticancer treatment

Design and Synthesis of 3,5-Disubstituted-1,2,4-Oxadiazoles as Potent Inhibitors of Phosphodiesterase4B2

Therapeutic benefit of PDE4 inhibitors in inflammatory diseases

RBx10080307, a dual EGFR/IGF-1R inhibitor for anticancer therapy

Chronic obstructive pulmonary disease: role of matrix metalloproteases and future challenges of drug therapy

Prostaglandin E 2 synthase inhibition as a therapeutic target

Prostaglandin E2 synthase inhibition as a therapeutic target

Synthesis of 4β-amido and 4β-sulphonamido analogues of podophyllotoxin as potential antitumour agents

An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors

Development of a cell death-based method for the screening of nuclear factor-κB inhibitors

Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: A novel, long acting muscarinic receptor antagonist

Development of cell death-based method for the selectivity screening of caspase-1 inhibitors

Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase

Synthesis and biological evaluation of new 4β-anilino- and 4β-imido-substituted podophyllotoxin congeners

Therapeutic potential of Aurora kinase inhibitors in cancer

Design, synthesis, biological evaluation and QSAR studies of novel bisepipodophyllotoxins as cytotoxic agents

Progress in the development of small molecule inhibitors of insulin-like growth factor-1 receptor kinase

Synthesis and Biological Activity of New 4β-N-Heteroaryl Analogues of Podophyllotoxin

Suchergebnisse filtern